Download in electronic PDF format for $25



Search the Complete Journal Archives

Basics of Compounding: Standardization of Compounded Medications

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2019 - Volume 23, Number 1
View All Articles in Issue

Abstract:  The feasibility of standardizing concentrations of compounded drug preparations to attempt to minimize adverse events of both nonsterile and sterile compounded preparations has been discussed. It is critical that a wide variety of opinions and potential “unintended consequences” be aired in the public before an issue like this is recommended to become a standard. In this article, we combine the thoughts and recommendations of many practicing compounding pharmacists from both community and hospital practice sites that have contributed to this topic through the International Journal of Pharmaceutical Compounding’s Compounders’ Network List, a complimentary listserve for our subscribers to share information; ask questions; and provide answers, comments, and opinions. We discuss the advantages, disadvantages, and unintended consequences of standardized concentrations and provide input from numerous practitioners who are “on the front lines” daily.

Related Keywords: Loyd V. Allen Jr, PhD, RPh, standardization of compounded preparations, standardized drug concentrations, parenteral drugs, intravenous drug admixtures, nonsterile pediatric drugs, drug safety, children, quality assurance, medication errors, hospital pharmacy, Compounders Network List

Related Categories: LEGAL, PARENTERALS, PEDIATRICS, QUALITY CONTROL, ADVERSE DRUG EVENTS, HOSPITAL PHARMACY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Basics of Compounding: Standardization of Compounded Medications Allen Loyd V Jr Jan/Feb 2019 35-44 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Palma Elisabetta, Bufarini Celestino Sep/Oct 2014 358-364 Buy
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W May/Jun 2016 202-206 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna Nov/Dec 2012 456-460 Buy
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A Nov/Dec 2011 526-527 Buy
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D Jan/Feb 2005 44-46 Buy
Documentation: Records and Reports Akers Michael J Sep/Oct 2017 373-380 Buy